dc.contributor.author
Gröschel, Jan
dc.contributor.author
Grassow, Leonhard
dc.contributor.author
van Dijck, Phillip
dc.contributor.author
Bhoyroo, Yashraj
dc.contributor.author
Blaszczyk, Edyta
dc.contributor.author
Schulz-Menger, Jeanette
dc.date.accessioned
2025-07-28T15:41:13Z
dc.date.available
2025-07-28T15:41:13Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/48447
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-48169
dc.description.abstract
Introduction: Myocardial tissue alterations in patients with post-Coronavirus disease 2019 syndrome (PCS) are often subtle and mild. Reports vary in the prevalence of non-ischemic and ischemic injuries as well as the extent of ongoing myocardial inflammation. The exact relevance of these myocardial alterations is not fully understood. This study aimed at describing the trajectories of myocardial alterations in PCS patients by mid-term follow-up with cardiovascular magnetic resonance (CMR).
Methods: This study entails a retrospective analysis of symptomatic PCS patients referred for follow-up CMR between August 2020 and May 2023 due to mildly affected or reduced left or right ventricular function (LV and RV, respectively) and structural myocardial alterations, e.g., focal and diffuse fibrosis, on baseline scans. Follow-up CMR protocol consisted of cine images and full coverage native T1 and T2 mapping. Baseline and follow-up scans were compared using t-tests or Wilcoxon tests. Post-hoc analysis was carried out in a subgroup based on the change of LV stroke volume (SV) between scans.
Results: In total, 43 patients [median age (interquartile range) 46 (37–56) years, 33 women] received follow-ups 347 (167–651) days after initial diagnosis. A decrease in symptoms was recorded on follow-ups (p < 0.03) with 23 patients being asymptomatic at follow-ups [symptomatic at baseline 43/43 (100%) vs. symptomatic at follow-up 21/43 (49%), p < 0.001]. Functional improvement was noted for LV-SV [83.3 (72.7–95.0) vs. 84.0 (77.0–100.3) ml; p = 0.045], global radial [25.3% (23.4%–27.9%) vs. 27.4% (24.4%–33.1%); p < 0.001], and circumferential strains [−16.5% (−17.5% to −15.6%) vs. −17.2% (−19.5% to −16.1%); p < 0.001]. In total, 17 patients had an LV-SV change >10% on follow-up scans (5 with a decrease and 12 with an increase), with LV-SV, RV-SV, and global longitudinal strain being discriminatory variables on baseline scans (p = 0.01, 0.02, and 0.04, respectively). T1- or T2-analysis revealed no changes, remaining within normal limits.
Conclusion: Symptomatic load as well as blood pressures decreased on follow-up. CMR did not detect significant changes in tissue parameters; however, volumetric, specifically LV-SV, and deformation indexes improved during mid-term follow-up.
en
dc.rights.uri
https://creativecommons.org/licenses/by/4.0/
dc.subject
cardiovascular magnetic resonance
en
dc.subject
post-COVID-19 syndrome
en
dc.subject
late gadolinium enhancement
en
dc.subject
stroke volume
en
dc.subject.ddc
600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und Gesundheit
dc.title
Trajectories of functional and structural myocardial parameters in post-COVID-19 syndrome—insights from mid-term follow-up by cardiovascular magnetic resonance
dc.type
Wissenschaftlicher Artikel
dcterms.bibliographicCitation.articlenumber
1357349
dcterms.bibliographicCitation.doi
10.3389/fcvm.2024.1357349
dcterms.bibliographicCitation.journaltitle
Frontiers in Cardiovascular Medicine
dcterms.bibliographicCitation.originalpublishername
Frontiers Media SA
dcterms.bibliographicCitation.volume
11
refubium.affiliation
Charité - Universitätsmedizin Berlin
refubium.resourceType.isindependentpub
no
dcterms.accessRights.openaire
open access
dcterms.bibliographicCitation.pmid
38628318
dcterms.isPartOf.eissn
2297-055X